Elizabeth Arkema
@elizabetharkema.bsky.social
1.1K followers 370 following 240 posts
Principal Researcher & Docent in Epidemiology @ Karolinska Institute |autoimmune disease|epidemiology | statistics | sarcoidosis | lupus
Posts Media Videos Starter Packs
elizabetharkema.bsky.social
There has been a suggestion of a shared genetic risk between some cancers and sarcoidosis. This might explain the slightly increased risk of cancer associated with sarcoidosis that persists for years.
elizabetharkema.bsky.social
We need a better evidence base for choosing treatments. If someone has a history of cancer, what treatment for sarcoidosis is best? Do sarcoidosis treatments increase cancer risk? We show that sarcoidosis, regardless of treatment is associated with cancer. How should people be screened?
elizabetharkema.bsky.social
Really enjoyed presenting my poster on malignancy risk associated with sarcoidosis. I got some great questions and comments from people - and now I have like 10 more study ideas 😂 first I need to finish this study! #ERS2025
elizabetharkema.bsky.social
“Don’t look for certainty in the science of uncertainty- it’s like looking for snow in the dessert” - Nicola Orsini ending his talk on statistical thinking in public health #episky
elizabetharkema.bsky.social
How to predict prolonged pregnancy outcomes, to identify who should be induced at week 41? When you introduce a new intervention, planning ahead and making time/space and having funding should be considered
elizabetharkema.bsky.social
We still need more data to build good prediction models - they are still not good enough (e.g. predicting vaginal birth after a first birth via cesarean )
elizabetharkema.bsky.social
A lot of effort has been put into predicting preeclampsia - using all the information we already collect, we can improve prediction.
elizabetharkema.bsky.social
Next: NIPT test - a blood sample which detects cell-free fetal DNA if KUB shows high risk. Now only 1% of pregnancies have amniocentesis.
elizabetharkema.bsky.social
Professor Olof Stephansson from Karolinska is our next speaker - we need precision medicine in obstetrics. One example: trisomy detection (Down’s syndrome). Initially only maternal age was used to identify pregnancies for amniocentesis. Then ultrasound was added and now KUB, improves accuracy.
elizabetharkema.bsky.social
We need to be more rigorous - need to test and validate in multiple cohorts. How do we take what we learn in academia into clinical care?
elizabetharkema.bsky.social
He gave really good examples of identifying preclinical biomarkers in IBD. Signatures for treatment response did not pan out. Future: get longitudinal samples to capture dynamics. The heterogeneity of patients is a challenge.
elizabetharkema.bsky.social
Next presentation: Professor Jonas Halfvarsson from Örebro University on precision medicine in inflammatory bowel disease. They have developed diagnostic lipid and protein signatures
elizabetharkema.bsky.social
A framework for clinical translation in precision medicine
elizabetharkema.bsky.social
An example: using unsupervised clustering to identify novel subgroups of diabetes. However the clusters identified were not clinically useful.
elizabetharkema.bsky.social
The next speaker is Professor Paul Franks from Lund University who explains why we need precision medicine for cardiometabolic diseases like diabetes. #episky
elizabetharkema.bsky.social
It takes 17 years for interventions to reach 14% of the populations. It takes a long time for them to be included in clinical guidelines- stakeholders should be involved earlier to make sure the interventions are acceptable
elizabetharkema.bsky.social
Implementation science goes from pre-intervention, efficacy studies, effectiveness studies and implementation. It should be thought of earlier so that interventions can reach people quicker
elizabetharkema.bsky.social
We should do more investigation of the effectiveness of population public health interventions
elizabetharkema.bsky.social
There are opportunities in different areas to move forward with precision public health: capacity building, equity research, implementation science, data science & AI, ELSI research
elizabetharkema.bsky.social
First speaker of the day, Assistant Professor Megan Roberts from University of North Carolina explains what precision public health is: the right intervention at the right time to the right population. #episky
elizabetharkema.bsky.social
Strategic research in epidemiology day has started! @ki.se
The theme is precision medicine and we have a great line-up of speakers
elizabetharkema.bsky.social
At a responsible internationalization seminar:
It is a national security risk to _not_ collaborate internationally - we will otherwise not understand eachother, and not have connections to experts in other countries.